Brief: AB Science Issues Clarification Following Feb 11, 2022 Public Hearing Of Enforcement Committee Of French Market Regulator

AB Science SA

12/02/2022 19:56

Feb 12 (Reuters) - AB Science SA  ABS.PA :
    * CLARIFICATION FOLLOWING FEBRUARY 11, 2022 PUBLIC HEARING
OF
ENFORCEMENT COMMITTEE OF FRENCH MARKET REGULATOR
    * AMF TEAM UPHELD COMPLAINTS FOR NOT HAVING COMMUNICATED
INFORMATION RELATING TO MARKETING AUTHORIZATION PROCEDURE FOR
MASITINIB IN MASTOCYTOSIS
    * AMF TEAM UPHELD COMPLAINTS AGAINST ALAIN MOUSSY FOR HAVING
USED
PRIVILEGED INFORMATION TO SELL PART OF SHARES,  REQUESTED
FINANCIAL PENALTIES
    * AB SCIENCE AND ALAIN MOUSSY HAVE FIRMLY AND SPECIFICALLY
CONTESTED THESE ALLEGATIONS
    * RAPPORTEUR OF ENFORCEMENT COMMITTEE, ON BASIS OF REPORT,
CONSIDERED SUCH  INFORMATION DID NOT EXIST DURING
FUNDRAISING,SALE BY MOUSSY
    * DECISION OF ENFORCEMENT COMMITTEE IS EXPECTED IN FOUR TO
SIX
WEEKS

Source text for Eikon:  ID:nGNE59FQs6 
Further company coverage:  ABS.PA 

 ((Reuters.Briefs@thomsonreuters.com;))